Fouad Nawaz

CIK: 0002030838

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EXOZ

EXOZYMES INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

EXOZ
EXOZYMES INC.
Sep 14, 2026
Award(A)
Stock Option (right to buy)
Direct
45K shares-
EXOZ
EXOZYMES INC.
Apr 1, 2026
Award(A)
Direct
6K shares at avg. $8.44$51K
EXOZ
EXOZYMES INC.
Jun 13, 2025
Award(A)
Direct
3.5K shares at avg. $12.54$44K

		Type	Shares	Price		Ownership
Sep 14, 2026	EXOZ EXOZYMES INC.	Award(A) Stock Option (right to buy)	45,000	-	-	Direct
Apr 1, 2026	EXOZ EXOZYMES INC.	Award(A)	5,999	$8.44	$50,632	Direct
Jun 13, 2025	EXOZ EXOZYMES INC.	Award(A)	3,489	$12.54	$43,752	Direct

1-3 of 3 transactions

About Nawaz Fouad

Nawaz Fouad (SEC CIK 0002030838) files insider reports with the SEC as Vice President- Finance of EXOZYMES INC. (EXOZ).

Signal8 holds 4 ownership filings by Nawaz Fouad (1 Form 3, 3 Form 4), filed between Nov 18, 2024 and Sep 17, 2026. Those filings report 3 transactions, from Jun 13, 2025 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Nawaz Fouad's filings is in MONROVIA, CA.

Recent filings by Nawaz Fouad

Sep 14, 2026: Grant or award of EXOZ derivative securities (Form 4, code A).
Apr 1, 2026: Grant or award of EXOZ shares (Form 4, code A).
Jun 13, 2025: Grant or award of EXOZ shares (Form 4, code A).

Other insiders filing for EXOZYMES INC. (EXOZ)

Perriman Damien Alan, Chief Commercial Officer
Korman Tyler Paz, Chief Scientific Officer
Rayo Edgardo Javier, Director
MARLETT CHRISTOPHER A, Director
Lalonde James Joseph, Director
DIGIANDOMENICO ANTHONY, Director

How to read Form 4 transaction codes